<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="107545">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01863563</url>
  </required_header>
  <id_info>
    <org_study_id>version 4 September 2012</org_study_id>
    <nct_id>NCT01863563</nct_id>
  </id_info>
  <brief_title>Safety Study of Quickclot for Bleeding Control After Adenotonsillectomy</brief_title>
  <official_title>Hemostatic Control After Adenotonsillectomy- Open Label QuikClot Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eastern Virginia Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eastern Virginia Medical School</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hemostasis will be achieved during Pediatric Tonsillectomy/Adenoidectomy with  the use of
      QuickClot.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Quickclot dressing contains Kaolin, a natural mineral that promotes the body's clotting
      process. This dressing will be applied for one minute to the area where the tonsils/adenoids
      were.  The investigators are hoping to develop a standard of practice where Quickclot is a
      key addition for tonsillectomy surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>total suction electrocautery time required for hemostasis will be recorded as seconds</measure>
    <time_frame>at the time of surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>After removal of the adenoids, a tonsil pack wrapped in QuikClot will be placed in the nasopharynx.  The investigators will then perform tonsillectomy with the Microdebrider.  A QuikClot roll will be placed in the tonsil fossa, and pressure applied via tonsil sponge for one minute.  The contralateral tonsil will then be addressed with the same technique.  The QuikClot adenoid pack is then removed and residual adenoidal bleeding is addressed with suction electrocautery, followed by placement of a second QuikClot adenoid pack.  The tonsil rolls are sequentially removed, followed by control of residual hemostasis with suction electrocautery.  A second set of tonsil rolls are placed.  After adenoid pack is removed from nasopharynx and bleeding controlled, tonsil rolls are removed, followed by suction electrocautery for any residual hemostasis is performed.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Sleep Apnea, Obstructive</condition>
  <arm_group>
    <arm_group_label>QuickClot</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>QuickClot sponge will be applied for one minute each site of tonsillectomy and Adenoidectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>QuickClot</intervention_name>
    <arm_group_label>QuickClot</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of adenotonsillar hypertrophy causing obstructive sleep disorders

        Exclusion Criteria:

          -  Patients with signs or symptoms of obstructed breathing

          -  recurrent pharyngitis

          -  history of bleeding disorder

          -  history of prior adenotonsillectomy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Craig Derkay, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>EVMS Department of Otolaryngology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Craig Dekay, MD</last_name>
    <phone>757-668-9327</phone>
    <email>Craig.Derkay@chkd.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laura Stone, BSN</last_name>
    <phone>757-388-6238</phone>
    <email>stonelj@evms.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital of the Kings Daughters</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Stone, BSN</last_name>
      <phone>757-388-6238</phone>
      <email>stonelj@evms.edu</email>
    </contact>
    <investigator>
      <last_name>Craig Derkay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 13, 2014</lastchanged_date>
  <firstreceived_date>May 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tonsillectomy</keyword>
  <keyword>adenoidectomy</keyword>
  <keyword>obstructive sleep apnea</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
